Trial · NCT03181399
Outcomes12
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 12 of 12
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Neuropsychological Score of Sustained Attention | Change post 6 months of treatment | Although 29 patients completed the 6-month treatment phase, some patients were unable to perform the test due to cognitive or physical impairment. The analysis population comprises of participants who were present at the time of testing and were able to comprehend and perform the test. | Participants | COUNT_OF_PARTICIPANTS |
| PRIMARY | Neuropsychological Score of Sustained Attention | Change after 3 months off treatment | Although 28 patients completed the 3-month treatment phase, some patients were unable to perform the test due to cognitive or physical impairment. The analysis population comprises of participants who were present at the time of testing and were able to comprehend and perform the test. | Participants | COUNT_OF_PARTICIPANTS |
| PRIMARY | Neuropsychological Score of Working Memory Index Scale (WMI) | Change post 6 months of treatment | Some patients were unable to perform the test due to cognitive, physical impairment or underdeveloped vocabulary skills. The analysis population comprises of participants who were present at the time of testing and were able to comprehend and perform the test. | Participants | COUNT_OF_PARTICIPANTS |
| PRIMARY | Neuropsychological Score of Working Memory Index Scale (WMI) | Change after 3 months off-treatment | Some patients were unable to perform the test due to cognitive, physical impairment or underdeveloped vocabulary skills. The analysis population comprises of participants who were present at the time of testing and were able to comprehend and perform the test. | Participants | COUNT_OF_PARTICIPANTS |
| PRIMARY | Neuropsychological Score of Processing Speed Index (PSI) | Change post 6 months of treatment | Some patients were cognitively unable to perform or comprehend the test. The analysis population comprises of participants who were present at the time of testing and were able to comprehend and perform the test. | Participants | COUNT_OF_PARTICIPANTS |
| PRIMARY | Neuropsychological Score of Processing Speed Index (PSI) | Change after 3 months off-treatment | Some patients were cognitively unable to perform or comprehend the test. The analysis population comprises of participants who were present at the time of testing and were able to comprehend and perform the test. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | EEG Changes: Generalized Spike Wave Activity and Burst | Change post 6 months of treatment | Out of 45 enrolled, 29 patients completed the 6 month treatment period | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | EEG Changes: Generalized Spike Wave Activity and Burst | Change after 3 months off-treatment | Out of 29 patients who completed the treatment period, 28 returned for the 3 month off-treatment visit. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Brief Ataxia Rating Scale | Change post 6 months of treatment | Although 29 patients completed the study, some patients were unable to perform the test due to physical impairment and inability to comprehend the task. Here, the number of participants analyzed reflects the total number of patients that were present at the test and were able to complete it. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Brief Ataxia Rating Scale | Change after 3 months off treatment | Although 28 patients completed the off-treatment phase of study, some patients were unable to perform the test due to physical impairment and inability to comprehend the task. Here, the number of participants analyzed reflects the total number of patients that were present at the test and were able to comprehend it. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Clinical Global Impression Severity Scale | Change post 6 months of treatment | Out of the 45 patients enrolled, 29 completed the 6 month treatment phase. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Clinical Global Impression Severity Scale | Change after 3 months off-treatment | Out of the 29 patients that completed the treatment phase, 28 completed the following 3 month off-treatment phase. The assessment was incomplete for one patient due to inability to report symptoms. | Participants | COUNT_OF_PARTICIPANTS |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03181399/outcomes